enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
enGene Holdings Inc. Reports Grant of Inducement Equity Awards Introduction enGene Holdings Inc., a clinical-stage genetic medicines company, has announced the grant of inducement equity awards to its employees. The company, which is known for its non-viral lead investigational product detalimogene voraplasmid, is currently conducting a pivotal study in patients with high-risk, BCG-unresponsive, non-muscle invasive…